Recent Advances in the Management of
Insomnia: New Considerations in Treatment Strategies
A continuing medical education
activity provided by NAMCP and AAMCN
This activity is an archive from the live session from the 2020 Fall
Managed Care Forum. If you participated in the live session, you are
not eligible for continuing education credits from this archive.
This activity is valid from February 1, 2021 to March 1, 2022
|
Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
|
Audience:
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by
an educational grant from Eisai
Description:
Insomnia is a sleep disorder which makes it difficult to fall asleep
or stay asleep, even when a person has the chance to do so. This can
affect a person’s sleep so much that they still feel tired after
they wake up. Lack of sleep can sap your energy level, affects your
mood, and causes stress with your health, work performance and
quality of life. If not treated properly, insomnia can lead to other
adverse effects such as anxiety, depression, irritability,
concentration and memory problems, poor immune system function, and
reduced reaction time. Many adults experience acute insomnia, which
last for days or weeks and is usually the result of stress or a
traumatic event in one’s life. Some experience chronic insomnia
which can last for a month or more. There are 60 million Americans
affected by the disease and about 25% of them experience acute
insomnia each year, with around 10% experiencing chronic insomnia.
There are several different approaches to the diagnosis of insomnia
although there is no definitive test for it. Tools used for
diagnosing the disease include a sleep log, which tracks the details
of a person’s sleep, sleep inventory of sleeping patterns, blood
tests and undergoing a sleep study. These tests help determine the
level of insomnia and what treatment plan should be utilized.
Insomnia continues to be underdiagnosed and undertreated.
Identifying sleep hygiene issues can raise awareness of sleep
patterns that need to be changed. Cognitive behavioral therapy has
proven efficacy as first-line treatment for insomnia. This can
include stimulus control therapy, relaxation techniques, and sleep
restriction. However, there are some patients that do not respond to
nonpharmacologic treatments and they need to supplement a patient’s
nonpharmacologic treatment with a pharmacologic agent. There are
currently new treatments that are in clinical trials, including a
dual orexin receptor antagonist, which will help regulate sleep by
dampening wakefulness without stopping the ability to awaken the
external stimuli.
Upon completion of this
activity, participants will be able to:
-
Discuss the current guideline
recommendations for the treatment and management of insomnia to
help inform appropriate treatment decisions
-
Assess clinical data and outcomes
measures for optimal diagnostic testing for patients with
insomnia
-
Examine the clinical data for the
safety and efficacy profiles for pharmacologic therapies for the
treatment of insomnia
-
Describe the current and emerging
treatment considerations for insomnia, including ways to manage
residual effects
-
Analyze the challenges associated
with treatment and managing insomnia, including patient
adherence and untreated insomnia
Faculty: |
Larry Culpepper, MD, MPH
Professor of Family Medicine
Department of Family Medicine
Boston University School of Medicine |
Disclosure:
|
Dr.
Culpepper serves on an advisory board for AbbVie,
Acadia, Allergan, Eisai, Merck, and Takeda. He has
received royalties from UpToDate and Oxford University
Press. He owns stock in M-3 Information, LLC. His
presentation has been peer reviewed for any bias. |
|
Planning Committee:
Bill Williams,
MD has no real or perceived financial relationships to
disclose.
Jeremy Williams has no real or perceived financial
relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived
financial relationships to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity. |
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
requirements.
This activity is supported by an educational grant from
Eisai
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
professional.
Click Here To Continue |